← Leaderboards
Soren Matthew Gantt
Seattle Children'S Hospital
$1,896,931
Attributed
$2,850,592
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2011–22$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$10,548,501 · 4
By mechanism
P01$10,251,540 · 3
R21$296,961 · 1
Top collaborators
- Serge Barcy11 shared
- Michael Lagunoff6 shared
- Timothy M Rose6 shared
- Jeffrey Vieira6 shared
- Isabelle Boucoiran2 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Serge Barcy$1,739,341
- Douglas S Hawkins$670,498
- James M Olson$23,190,448
- Margarett Shnorhavorian$3,247,404
- Russ Geyer$1,091,565
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionTransmission ProcessOralViralS SarcomaImmune ResponseInstructionMalignant NeoplasmsParentsOropharyngealHerpesviridae InfectionsKaposi SarcomaImmuneAreaChildhoodPathogenesisUgandaCellsAfrica South Of The SaharaPreventBloodSalivaCohortChild
Grant awards (18)
CMV Dynamics and Transmission Among Pregnant Women Living with HIV$133,870
R21 · FY2022 · HD
CMV Dynamics and Transmission Among Pregnant Women Living with HIV$163,091
R21 · FY2021 · HD
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,610,585
P01 · FY2015 · DE
Immune Control of KSHV Infection and Impact of HIV Infection and Therapy$334,667
P01 · FY2015 · DE · contact PI
Clinical Core$198,695
P01 · FY2015 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,603,989
P01 · FY2014 · DE
Immune Control of KSHV Infection and Impact of HIV Infection and Therapy$327,709
P01 · FY2014 · DE · contact PI
Clinical Core$211,470
P01 · FY2014 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,335,154
P01 · FY2013 · DE
Immune Control of KSHV Infection and Impact of HIV Infection and Therapy$278,636
P01 · FY2013 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$234,324
P01 · FY2013 · DE
Clinical Core$169,650
P01 · FY2013 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,406,029
P01 · FY2012 · DE
Immune Control of KSHV Infection and Impact of HIV Infection and Therapy$289,925
P01 · FY2012 · DE · contact PI
Clinical Core$186,523
P01 · FY2012 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,507,828
P01 · FY2011 · DE
Immune Control of KSHV Infection and Impact of HIV Infection and Therapy$379,424
P01 · FY2011 · DE · contact PI
Clinical Core$176,932
P01 · FY2011 · DE · contact PI